RheaVita Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

RheaVita General Information

Description

Developer of a continuous freeze-drying technology designed to improve pharmaceutical manufacturing processes. The company's platform includes advanced lyophilization methods, rapid formulation development, and compliant production systems, enabling pharmaceutical companies to enhance efficiency and overcome limitations of batch processing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Poortakkerstraat 9C
  • 9051 Gent
  • Belgium
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Poortakkerstraat 9C
  • 9051 Gent
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RheaVita Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
4. Secondary Transaction - Private 18-Nov-2024 Completed Generating Revenue
3. Early Stage VC (Series A) 02-Jun-2021 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2018 Completed Startup
To view RheaVita’s complete valuation and funding history, request access »

RheaVita Patents

RheaVita Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026224317-A1 Method and device for spin freezing Pending 23-Apr-2025
EP-4453491-A1 Device and method for freeze-drying liquid-containing composition Pending 22-Dec-2021
WO-2023118392-A1 Device and method for freeze-drying liquid-containing composition Inactive 22-Dec-2021
US-20250060159-A1 Device and method for freeze-dryng liquid-containing composition Pending 22-Dec-2021
AU-2021373282-A1 Method and apparatus for freezing or thawing mixtures comprising water Active 04-Nov-2020 F26B5/06
To view RheaVita’s complete patent history, request access »

RheaVita Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RheaVita Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator
Industria Macchine Automatiche PE-Backed Company Minority
Novalis Biotech Venture Capital Minority
PMV (Belgium) Asset Manager Minority
Ghent University University
You’re viewing 5 of 6 investors. Get the full list »

RheaVita FAQs

  • When was RheaVita founded?

    RheaVita was founded in 2018.

  • Where is RheaVita headquartered?

    RheaVita is headquartered in Gent, Belgium.

  • What is the size of RheaVita?

    RheaVita has 13 total employees.

  • What industry is RheaVita in?

    RheaVita’s primary industry is Other Devices and Supplies.

  • Is RheaVita a private or public company?

    RheaVita is a Private company.

  • What is RheaVita’s current revenue?

    The current revenue for RheaVita is .

  • How much funding has RheaVita raised over time?

    RheaVita has raised $3.04M.

  • Who are RheaVita’s investors?

    European Innovation Council, Industria Macchine Automatiche, Novalis Biotech, PMV (Belgium), and Ghent University are 5 of 6 investors who have invested in RheaVita.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process